Ventricular Tachycardia (VT) is a cardiac arrhythmia characterized by a rapid and regular heartbeat originating in the heart's lower chambers, the ventricles. In VT, the heart beats at a significantly faster rate than normal, disrupting its regular rhythm. This condition poses serious health risks as it may lead to inadequate blood flow to the body and, in severe cases, progress to more life-threatening arrhythmias. Ventricular Tachycardia can occur in individuals with pre-existing heart conditions, such as coronary artery disease or structural heart abnormalities, but it can also manifest in those with otherwise healthy hearts. Prompt diagnosis and management are crucial to prevent complications and improve patient outcomes, often involving anti-arrhythmic medications, catheter ablation, or, in severe cases, implantable cardioverter-defibrillator (ICD) placement. Regular monitoring and collaboration between healthcare professionals play a vital role in effectively addressing Ventricular Tachycardia and ensuring the well-being of affected individuals.
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through bio design-driven translational applications and cardiology-related marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries, and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Biomechanical evaluation of sternal closure stability with and without demineralized bone matrix graft: An FEA study
Ravi Kanagala, LCMC Health, United States
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States